This page is best viewed fullscreen on your desktop/tablet. If you are using a mobile device please rotate it to landscape mode.
ACTIVE CLINICAL PIPELINE
Allogeneic Placenta-derived Cell Therapy Product Candidates
We aim to advance human health, quality of life, and longevity through the power of placental allogeneic cells.
Developing Cell Therapies for a Range of Diseases
Celularity is investigating allogeneic cell therapies that are ready-to-use and eliminate the need for matching patients with donors.
We already have a number of products in clinical trials for hematological cancers and solid tumors as well as allergy and autoimmune diseases, even though we are only in the early stages of unlocking the full potential of our disruptive Celularity IMPACT™ platform (Immuno-Modulatory Placenta-derived Allogeneic Cell Therapy).